Failure is not an option: Barriers to HIV treatment adherence in Kampala, Uganda
- PMID: 33276263
- PMCID: PMC10103613
- DOI: 10.1016/j.healthplace.2020.102481
Failure is not an option: Barriers to HIV treatment adherence in Kampala, Uganda
Abstract
This study seeks to investigate challenges to combined antiretroviral therapy (cART) treatment adherence and treatment outcomes in Kampala, Uganda. Data was collected from a survey administered to two cohorts of patients with human immunodeficiency virus type 1 (HIV-1) receiving care and cART from the Joint Clinical Research Center (JCRC) in Kampala. Cohort I consisted of 93 individuals successfully treated on cART for a period of three years, while Cohort II consisted of 56 individuals who have experienced treatment failure with first-line cART within two years. We hypothesize that distance to the treatment facility would be a predictor of poor adherence and thus treatment failure. However, results suggested otherwise, whereby participants living more than 2 h away from their treatment facility were actually less likely to miss their daily dose of cART (OR = 0.33, p < .05), compared to those living in proximity to the treatment center. Further, high-income employment (OR = 3.82, p < .05) and partnered relationship status (OR = 4.28, p < .05) were predicted to increase the probability of missing doses. These findings may be explained by the deep-seated stigma which has remained pervasive in the lives of HIV-positive population in Kampala, even 30 years after the peak of the HIV/AIDS epidemic.
Keywords: Adherence; Antiretroviral therapy; HIV/AIDS; Stigma; Uganda.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declarations of interest: Dr. Kityo is the executive director of the JCRC. Miriam Namasinga and Ritah Katasi are also employed by the clinic.
Figures
Similar articles
-
"…So that's why we hide, we don't want them to know"- Challenges to Antiretroviral Therapy Adherence in Kampala, Uganda.Afr Geogr Rev. 2024;43(1):18-31. doi: 10.1080/19376812.2022.2101496. Epub 2022 Jul 18. Afr Geogr Rev. 2024. PMID: 38576439 Free PMC article.
-
Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: the experience of The AIDS Support Organization (TASO), Kampala, Uganda.BMC Health Serv Res. 2008 Nov 20;8:241. doi: 10.1186/1472-6963-8-241. BMC Health Serv Res. 2008. PMID: 19021908 Free PMC article.
-
Predictors of Treatment Failure in HIV-Positive Children Receiving Combination Antiretroviral Therapy: Cohort Data From Mozambique and Uganda.J Pediatric Infect Dis Soc. 2015 Mar;4(1):39-48. doi: 10.1093/jpids/piu032. Epub 2014 May 3. J Pediatric Infect Dis Soc. 2015. PMID: 26407356
-
Human immunodeficiency virus neurological complications: an overview of the Ugandan experience.J Neurovirol. 2005;11 Suppl 3:26-9. doi: 10.1080/13550280500511782. J Neurovirol. 2005. PMID: 16540451 Review.
-
Human immunodeficiency virus and AIDS in Uganda.East Afr Med J. 1996 Jan;73(1):20-6. East Afr Med J. 1996. PMID: 8625856 Review.
Cited by
-
Social Networks and Barriers to ART Adherence Among Young Adults (18-24 years) Living with HIV at Selected Primary Health Facilities of South-Western Uganda: A Qualitative Study.HIV AIDS (Auckl). 2021 Oct 7;13:939-958. doi: 10.2147/HIV.S328643. eCollection 2021. HIV AIDS (Auckl). 2021. PMID: 34675686 Free PMC article.
-
"…So that's why we hide, we don't want them to know"- Challenges to Antiretroviral Therapy Adherence in Kampala, Uganda.Afr Geogr Rev. 2024;43(1):18-31. doi: 10.1080/19376812.2022.2101496. Epub 2022 Jul 18. Afr Geogr Rev. 2024. PMID: 38576439 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical